Outlook Therapeutics (OTLK) FCF Margin (QoQ) (2015 - 2025)
Outlook Therapeutics (OTLK) FCF Margin (QoQ) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Outlook Therapeutics |
51.13 Mn |
43.39 Mn |
-21,888.00 |
| Date | Value |
|---|
| Sep 30, 2025 |
1.43 Mn |
| Sep 30, 2019 |
180,470.00 |
| Jun 30, 2019 |
-91,166.00 |
| Mar 31, 2019 |
-4,576.00 |
| Dec 31, 2018 |
31,273.00 |
| Sep 30, 2018 |
-12,354.00 |
| Jun 30, 2018 |
-12,815.00 |
| Mar 31, 2018 |
26,326.00 |
| Dec 31, 2017 |
-126,457.00 |
| Sep 30, 2017 |
192,237.00 |
| Jun 30, 2017 |
-54,518.00 |
| Mar 31, 2017 |
55,862.00 |
| Dec 31, 2016 |
22,794.00 |
| Sep 30, 2016 |
117,108.00 |
| Jun 30, 2016 |
-262,818.00 |
| Mar 31, 2016 |
53,928.00 |
| Dec 31, 2015 |
164,714.00 |
| Sep 30, 2015 |
-184,663.00 |
